Glucose B. Braun (Glucose Monohydrate)

Glucose B. Braun is employed in clinical settings where intravenous carbohydrate and fluid replacement are required.

• Management of hypoglycemia when oral intake is not possible.
• Component of total parenteral nutrition formulations to supply energy.
• Fluid and electrolyte replacement in patients unable to tolerate oral fluids.
• Support during perioperative periods where fasting is mandated.
• Adjunct in pediatric or neonatal care for caloric supplementation.
• Use as a diluent for compatible intravenous medications requiring a carbohydrate carrier.

When administered intravenously, Glucose B. Braun may be associated with a range of observed effects, most of which are related to its glucose content and fluid volume.

Common

• Transient rise in blood glucose levels.
• Mild hyperosmolarity leading to temporary thirst.
• Local irritation at the infusion site if solution is not properly diluted.
• Electrolyte shifts such as mild hyponatremia due to fluid load.
• Mild nausea or abdominal discomfort.
• Temporary increase in urine output due to osmotic diuresis.

Serious

• Severe hyperglycemia, especially in patients with diabetes mellitus.
• Fluid overload resulting in pulmonary edema.
• Hyperosmolar hyperglycemic state (HHS) in susceptible individuals.
• Acute metabolic acidosis in patients with impaired renal function.

Glucose B. Braun should be administered with attention to patient-specific factors and clinical conditions to minimize risks.

• Verify blood glucose levels before and during infusion, especially in diabetic patients.
• Adjust infusion rate in individuals at risk for fluid overload, such as those with heart or renal failure.
• Use aseptic technique to prevent contamination of the intravenous solution.
• Monitor electrolytes, particularly sodium and potassium, as shifts may occur with large volumes.
• Avoid rapid infusion in neonates and infants to prevent hyperglycemia.
• Consider compatibility with other IV drugs; incompatibility may cause precipitation.
• Document any adverse reactions promptly in the patient record.

Glucose B. Braun may interact with other intravenous agents or systemic medications, influencing glucose homeostasis or fluid balance.

Avoid

• Co‑administration with high‑dose insulin infusions without appropriate monitoring.
• Simultaneous infusion of hypertonic saline solutions that could exacerbate hyperosmolarity.
• Mixing with calcium‑containing solutions that may precipitate.

Use with caution

• Concurrent use of diuretics, which may amplify fluid shifts.
• Administration alongside oral hypoglycemic agents; blood glucose should be closely observed.
• Use in patients receiving total parenteral nutrition containing other carbohydrate sources to avoid excess caloric load.
• Caution when combined with vasopressors, as rapid volume changes may affect hemodynamics.